Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingguang'an II decoction is a traditional Chinese medicine (TCM) multi-herb formulation with decades of clinical application, primarily indicated for glaucomatous optic neuropathy and the preservation of visual function in glaucoma. Studies demonstrate that it promotes optic nerve repair, preserves the visual field in glaucoma, and exerts neuroprotective effects on retinal ganglion cells (RGCs). The mechanism appears to involve attenuation of retinal ganglion cell pyroptosis via inhibition of the TRPV4/NF-κB signaling pathway, modulating inflammation and cell death in glaucomatous injury models[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qingguang'an ii decoction.